AI protein structure prediction market seen topping $6.6 billion by 2030

By AI, Created 5:08 PM UTC, May 18, 2026, /AGP/ – The global market for AI protein structure prediction is forecast to jump from $1.8 billion in 2025 to $2.33 billion in 2026, then reach $6.62 billion by 2030, according to The Business Research Company. The report points to precision medicine, drug discovery, and growing use of AI in bioinformatics as the main growth drivers.

Why it matters: - AI protein structure prediction is becoming a key tool in drug discovery, enzyme engineering and disease research. - The market’s rapid growth reflects wider demand for precision medicine and faster ways to analyze protein behavior. - The technology can help researchers understand protein folding and function more quickly and precisely than traditional methods.

What happened: - The Business Research Company released a 2026 market report on AI protein structure prediction. - The report estimates the market will rise from $1.8 billion in 2025 to $2.33 billion in 2026, a 29.6% CAGR. - The report forecasts the market will reach $6.62 billion by 2030, at a 29.8% CAGR. - The report includes coverage of Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

The details: - AI protein structure prediction uses machine learning and AI algorithms to infer a protein’s 3D shape from its amino acid sequence. - The report links near-term growth to advances in genomic and proteomic research. - Wider adoption of AI-based bioinformatics tools is also supporting expansion. - Drug discovery projects and computational biology applications are adding demand. - Academic and research institutions are increasing use of these tools. - The report says the market is also being pushed by rising demand for personalized medicine. - Cloud and hybrid IT infrastructure adoption is adding support for scale-up. - AI-powered disease diagnostics and biotechnology and pharmaceutical R&D investment are additional drivers. - High-throughput protein analysis platforms are contributing to market development. - In February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized therapies for rare diseases in 2023, up from 6 in 2022. - In 2025, North America held the largest share of the market. - The Asia-Pacific region is expected to be the fastest-growing market during the forecast period. - More information is available in the company’s announcement. - The full report is available here.

Between the lines: - The report suggests AI protein structure prediction is moving from a research niche into a core input for therapeutic discovery. - Precision medicine is a meaningful demand signal because it depends on understanding how molecular differences change protein function. - Regional momentum appears to be shifting, with North America still leading now and Asia-Pacific set to expand fastest.

What’s next: - The market is expected to keep compounding through 2030 as pharmaceutical and biotech spending stays strong. - Broader use of AI tools in diagnostics, bioinformatics and high-throughput analysis should expand commercial adoption. - Faster uptake in Asia-Pacific may reshape competitive positioning over the forecast period.